spacer
spacer
Go to PDB code: 
protein metals Protein-protein interface(s) links
Cytokine/immune system PDB id
1i9r
Jmol
Contents
Protein chains
143 a.a. *
219 a.a. *
215 a.a. *
Metals
_ZN ×3
* Residue conservation analysis
PDB id:
1i9r
Name: Cytokine/immune system
Title: Structure of cd40l in complex with the fab fragment of humanized 5c8 antibody
Structure: Cd40 ligand. Chain: a, b, c. Fragment: residues 116-261. Synonym: cd40-l. Engineered: yes. Immunoglobulin h. Chain: h, k, x. Immunoglobulin l. Chain: l, m, y
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: pichia pastoris. Expression_system_taxid: 4922. Cell_line: nso myeloma. Cell_line: nso myeloma
Biol. unit: Nonamer (from PQS)
Resolution:
3.10Å     R-factor:   0.233     R-free:   0.285
Authors: M.Karpusas,J.Lucci,J.Ferrant,C.Benjamin,Y.-M.Hsu
Key ref:
M.Karpusas et al. (2001). Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody. Structure, 9, 321-329. PubMed id: 11525169 DOI: 10.1016/S0969-2126(01)00590-1
Date:
20-Mar-01     Release date:   20-Mar-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P29965  (CD40L_HUMAN) -  CD40 ligand
Seq:
Struc:
261 a.a.
143 a.a.
Protein chain
No UniProt id for this chain
Protein chain
No UniProt id for this chain
Key:    PfamA domain  PfamB domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     membrane   1 term 
  Biological process     immune response   1 term 
  Biochemical function     tumor necrosis factor receptor binding     1 term  

 

 
DOI no: 10.1016/S0969-2126(01)00590-1 Structure 9:321-329 (2001)
PubMed id: 11525169  
 
 
Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody.
M.Karpusas, J.Lucci, J.Ferrant, C.Benjamin, F.R.Taylor, K.Strauch, E.Garber, Y.M.Hsu.
 
  ABSTRACT  
 
BACKGROUND: CD40 ligand (CD40L or CD154), a member of the tumor necrosis factor (TNF) family, plays a critical role in both humoral and cellular immune responses and has been implicated in biological pathways involving epithelial cells, fibroblasts, and platelets. Such a pathway is T cell-mediated B cell activation, a process that occurs through the interaction of CD40L with CD40 receptor expressed on B cells. It results in various B cell responses, including immunoglobulin isotype switching and B cell differentiation and proliferation. These responses can be inhibited by the monoclonal antibody 5c8, which binds with high affinity to CD40L. RESULTS: To understand the structural basis of the inhibition, we determined the crystal structure of the complex of the extracellular domain of CD40L and the Fab fragment of humanized 5c8 antibody. The structure shows that the complex has the shape of a three-bladed propeller with three Fab fragments bound symmetrically to a CD40L homotrimer. To further study the nature of the antibody-antigen interface, we assessed the ability of 23 site-directed mutants of CD40L to bind to 5c8 and CD40 and analyzed the results in the context of the crystal structure. Finally, we observed via confocal microscopy that 5c8 binding to CD40L on the cell surface results in the formation of patches of clustered complexes. CONCLUSIONS: The structure reveals that 5c8 neutralizes CD40L function by sterically blocking CD40 binding. The antigenic epitope is localized in a region of the surface that is likely to be structurally perturbed as a result of genetic mutations that cause hyper-IgM syndrome. The symmetric trimeric arrangement of the Fab fragments in the complex results in a geometry that facilitates the formation of large clusters of complexes on the cell surface.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. The Crystal Structure of the CD40L-5c8 Fab Complex in Ribbon RepresentationThe top view is along the three-fold axis, while the bottom view is perpendicular to the three-fold axis. The three CD40L monomers are colored yellow, green, and dark blue. The three Fab heavy chains are colored gray, dark gray, and magenta. The figure was made with RIBBONS [39]

 
  The above figure is reprinted by permission from Cell Press: Structure (2001, 9, 321-329) copyright 2001.  
  Figure was selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21050031 I.N.Ugwumba, K.Ozawa, L.de la Cruz, Z.Q.Xu, A.J.Herlt, K.S.Hadler, C.Coppin, S.E.Brown, G.Schenk, J.G.Oakeshott, and G.Otting (2011).
Using a genetically encoded fluorescent amino acid as a site-specific probe to detect binding of low-molecular-weight compounds.
  Assay Drug Dev Technol, 9, 50-57.  
20636329 E.Margolles-Clark, N.S.Kenyon, C.Ricordi, and P.Buchwald (2010).
Effective and specific inhibition of the CD40-CD154 costimulatory interaction by a naphthalenesulphonic acid derivative.
  Chem Biol Drug Des, 76, 305-313.  
20025827 S.J.Black, P.Guirnalda, D.Frenkel, C.Haynes, and V.Bockstal (2010).
Induction and regulation of Trypanosoma brucei VSG-specific antibody responses.
  Parasitology, 137, 2041-2049.  
20445236 Z.S.Derewenda (2010).
Application of protein engineering to enhance crystallizability and improve crystal properties.
  Acta Crystallogr D Biol Crystallogr, 66, 604-615.  
19475547 B.Yan, S.Steen, D.Hambly, J.Valliere-Douglass, T.Vanden Bos, S.Smallwood, Z.Yates, T.Arroll, Y.Han, H.Gadgil, R.F.Latypov, A.Wallace, A.Lim, G.R.Kleemann, W.Wang, and A.Balland (2009).
Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain.
  J Pharm Sci, 98, 3509-3521.  
19479954 C.J.Qi, L.Zheng, H.B.Ma, M.Fei, K.Q.Qian, B.R.Shen, C.P.Wu, M.Vihinen, and X.G.Zhang (2009).
A novel mutation in CD40 and its functional characterization.
  Hum Mutat, 30, 985-994.  
19672911 J.H.Mills, H.S.Lee, C.C.Liu, J.Wang, and P.G.Schultz (2009).
A genetically encoded direct sensor of antibody-antigen interactions.
  Chembiochem, 10, 2162-2164.  
19021159 M.Orzáez, A.Gortat, L.Mondragón, and E.Pérez-Payá (2009).
Peptides and peptide mimics as modulators of apoptotic pathways.
  ChemMedChem, 4, 146-160.  
17910054 L.A.Clark, and H.W.van Vlijmen (2008).
A knowledge-based forcefield for protein-protein interface design.
  Proteins, 70, 1540-1550.  
18647014 L.Zheng, I.O.Carbone, A.Lugovskoy, B.A.Berg, and W.Yang (2008).
A hybrid recursion method to robustly ensure convergence efficiencies in the simulated scaling based free energy simulations.
  J Chem Phys, 129, 034105.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.